{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T22:40:51Z","timestamp":1781304051165,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2007,12,22]],"date-time":"2007-12-22T00:00:00Z","timestamp":1198281600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s10067-007-0818-4","type":"journal-article","created":{"date-parts":[[2007,12,21]],"date-time":"2007-12-21T09:40:52Z","timestamp":1198230052000},"page":"891-897","source":"Crossref","is-referenced-by-count":22,"title":["Primary antiphospholipid syndrome in Latin American mestizo patients: clinical and immunologic characteristics and comparison with European patients"],"prefix":"10.1007","volume":"27","author":[{"given":"Rossana","family":"Mej\u00eda-Romero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Garc\u00eda-Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Galarza-Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Mendoza-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo O.","family":"Esc\u00e1rcega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Salinas-Saldivar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Soto-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelio","family":"L\u00f3pez-Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,12,22]]},"reference":[{"key":"818_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-044450987-1\/50003-6","volume-title":"The antiphospholipid syndrome II\u2014autoimmune thrombosis","author":"RA Asherson","year":"2002","unstructured":"Asherson RA, Cervera R, Piette JC, Shoenfeld Y (2002) Milestones in the antiphospholipid syndrome. In: Asherson R-A, Cervera R, Piette JC, Shoenfeld Y (eds) The antiphospholipid syndrome II\u2014autoimmune thrombosis. Elsevier, Amsterdam, pp 3\u20139"},{"key":"818_CR2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/08916939108997126","volume":"9","author":"J Font","year":"1991","unstructured":"Font J, L\u00f3pez-Soto A, Cervera R, Balasch J, Pallar\u00e9s L, Navarro M et al (1991) The \u2018primary\u2019 antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients. Autoimmunity 9:69\u201375","journal-title":"Autoimmunity"},{"key":"818_CR3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005792-198911000-00004","volume":"68","author":"RA Asherson","year":"1989","unstructured":"Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RHWM, Machin SJ, Barquinero J et al (1989) The \u201cprimary\u201d antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 68:366\u2013374","journal-title":"Medicine (Baltimore)"},{"key":"818_CR4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005792-198911000-00003","volume":"68","author":"D Alarc\u00f3n-Segovia","year":"1989","unstructured":"Alarc\u00f3n-Segovia D, Delez\u00e9 M, Oria CV, S\u00e1nchez-Guerrero J, G\u00f3mez-Pacheco L, Cabiedes J et al (1989) Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 68:353\u2013365","journal-title":"Medicine (Baltimore)"},{"key":"818_CR5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0049-0172(99)80029-8","volume":"29","author":"FJ Mu\u00f1oz-Rodr\u00edguez","year":"1999","unstructured":"Mu\u00f1oz-Rodr\u00edguez FJ, Font J, Cervera R, Reverter JC, T\u00e0ssies D, Espinosa G et al (1999) Clinical study and follow-up of 100 patients with the antiphospholipid syndrome. Semin Arthritis Rheum 29:182\u2013190","journal-title":"Semin Arthritis Rheum"},{"key":"818_CR6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9343(94)90108-2","volume":"96","author":"JL Vianna","year":"1994","unstructured":"Vianna JL, Khamashta MA, Ordi-Ros J, Font J, Cervera R, L\u00f3pez-Soto A et al (1994) Comparison of the primary and secondary antiphospholipid syndrome. A European multicenter study of 131 patients. Am J Med 96:3\u20139","journal-title":"Am J Med"},{"key":"818_CR7","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","volume":"12","author":"RA Asherson","year":"2003","unstructured":"Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC et al (2003) Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12:530\u2013534","journal-title":"Lupus"},{"key":"818_CR8","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1136\/ard.2005.038448","volume":"64","author":"I Uthman","year":"2005","unstructured":"Uthman I, Khamashta M (2005) Ethnic and geographical variation in antiphospholipid (Hughes) syndrome. Ann Rheum Dis 64:1671\u20131676","journal-title":"Ann Rheum Dis"},{"key":"818_CR9","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","volume":"46","author":"R Cervera","year":"2002","unstructured":"Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT et al (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46:1019\u20131027","journal-title":"Arthritis Rheum"},{"key":"818_CR10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemostas 4:295\u2013306","journal-title":"J Thromb Haemostas"},{"key":"818_CR11","first-page":"1802","volume":"20","author":"JC Piette","year":"1993","unstructured":"Piette JC, Wechsler B, Franc\u00e8s C, Papo T, Godeau P (1993) Exclusion criteria for primary antiphospholipid syndrome. J Rheumatol 20:1802\u20131804","journal-title":"J Rheumatol"},{"key":"818_CR12","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries J, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum 25:1271\u20131277","journal-title":"Arthritis Rheum"},{"key":"818_CR13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"818_CR14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"818_CR15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","year":"1980","unstructured":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581\u2013590","journal-title":"Arthritis Rheum"},{"key":"818_CR16","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.1780330802","volume":"33","author":"GG Hunder","year":"1990","unstructured":"Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF et al (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum 33:1065\u20131144","journal-title":"Arthritis Rheum"},{"key":"818_CR17","first-page":"215","volume":"68","author":"EN Harris","year":"1987","unstructured":"Harris EN, Gharavi AE, Patel SP, Hughes GRV (1987) Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 68:215\u2013222","journal-title":"Clin Exp Immunol"},{"key":"818_CR18","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1055\/s-0038-1649901","volume":"74","author":"JT Brandt","year":"1995","unstructured":"Brandt JT, Triplett DA, Alving B, Scharrer I (1995) Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 74:1185\u20131190","journal-title":"Thromb Haemost"},{"key":"818_CR19","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1196\/annals.1361.072","volume":"1051","author":"G Medina","year":"2005","unstructured":"Medina G, Vera-Lastra O, Angeles U, Jara LJ (2005) Mono-organic versus multiorganic involvement in primary antiphospholipid syndrome. Ann N Y Acad Sci 1051:304\u2013312","journal-title":"Ann N Y Acad Sci"},{"key":"818_CR20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.md.0000172074.53583.ea","volume":"84","author":"JA G\u00f3mez-Puerta","year":"2005","unstructured":"G\u00f3mez-Puerta JA, Martin H, Amigo MC, Aguirre MA, Camps MT, Cuadrado MJ et al (2005) Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus? Medicine (Baltimore) 84:225\u2013230","journal-title":"Medicine (Baltimore)"},{"key":"818_CR21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.autrev.2006.02.002","volume":"5","author":"L Stojanovich","year":"2006","unstructured":"Stojanovich L (2006) Pulmonary manifestations in antiphospholipid syndrome. Autoimmun Rev 5:344\u2013348","journal-title":"Autoimmun Rev"},{"key":"818_CR22","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.imbio.2005.10.005","volume":"210","author":"I Krause","year":"2005","unstructured":"Krause I, Blank M, Fraser A (2005) The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome. Immunobiol 210:749\u2013754","journal-title":"Immunobiol"},{"key":"818_CR23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1191\/096120399678847533","volume":"8","author":"E Cucurull","year":"1999","unstructured":"Cucurull E, Espinoza LR, Mendez E, Molina JF, Molina J, Ordi-Ros J et al (1999) Anticardiolipin and anti-\u03b22-glycoprotein I antibodies in patients with systemic lupus erythematosus: comparison between Colombians and Spaniards. Lupus 8:134\u2013141","journal-title":"Lupus"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0818-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-007-0818-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0818-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:11Z","timestamp":1559119871000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-007-0818-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,22]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["818"],"URL":"https:\/\/doi.org\/10.1007\/s10067-007-0818-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,22]]}}}